Dr. Juda Zurndorfer

Assistant Professor

Assistant Professor of Nursing
  • Campus:
    NYSCAS - New York School of Career and Applied Studies
  • Department:
    Nursing
Dr. Zurndorfer is an acute care nurse practitioner specializing in Neuro-intensive care with cross training in stroke and vascular neurology. Prior to specializing in Neurocritical care, Dr. Zurndorfer worked as a Registered Nurse in Medical and Surgical/Trauma intensive care units. He received his Doctorate of Nursing Practice from Rutgers University, and his Bachelors of Science of Nursing from the College of Mount Saint Vincent. 
Aside from clinical practice, Dr. Zurndorfer has published articles and is involved in multiple policy development projects including post cardiac arrest management of the ICU patient, blood pressure stabilization in intracerebral hemorrhage, multimodality monitoring in the Neuro-ICU patient, and development of the Neurocritical care lecture series for ACPs and ICU Nurses. Furthermore, Dr. Zurndorfer is also dedicated to his synagogue, organizing and assisting in events within his community as well as ensuring safe standards in developing his synagogues COVID-19 safety guidelines. 
Dr. Zurndorfer strives to inspire students to achieve the highest level of performance in the nursing practice and encourages all to treat patients with the most up to date evidence based practice.

 

Publications

  

Published Work:
In Progress.
Zurndorfer, J., Yakoby, J., Apold, S., & Hillman, P. (2023). Impact of asynchronous versus synchronous settings on academic performance in nursing education. Nurse Educator Today. (accepted).
Peer Reviewed.
Hamadi, R., Assaad, M., Zurndorfer, J., […] & Schwab, A. (2022). Intraparenchymal Hemorrhage: A Fatal Presentation of Undiagnosed Acute Myelogenous Leukemia. Cureus, 14(6), e25592. doi:10.7759/cureus.25592.
Schwab, A., Assaad, M., Hamadi, R., Zurndorfer, J. […] & Ibrahim, M. (2022). Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors. Journal of Medical Cases, 13(11): 530-535. doi:10.14740/jmc4008.